These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin. Toal M; Chaddha V; Windrim R; Kingdom J J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097 [TBL] [Abstract][Full Text] [Related]
4. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes. Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942 [TBL] [Abstract][Full Text] [Related]
5. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hershkovitz R; de Swiet M; Kingdom J Hypertens Pregnancy; 2005; 24(3):273-80. PubMed ID: 16263599 [TBL] [Abstract][Full Text] [Related]
6. The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes. Öztürk H; Erkaya S; Altınbaş S; Karadağ B; Vanlı Tonyalı N; Özkan D Turk J Obstet Gynecol; 2014 Sep; 11(3):142-147. PubMed ID: 28913007 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249 [TBL] [Abstract][Full Text] [Related]
8. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460 [TBL] [Abstract][Full Text] [Related]
10. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Spencer K Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Pregnancy Complications With Maternal Biochemical Markers Used in Down Syndrome Screening. Ozdemir S; Sahin O; Acar Z; Demir GZ; Ermin E; Aydin A Cureus; 2022 Mar; 14(3):e23115. PubMed ID: 35425672 [TBL] [Abstract][Full Text] [Related]
12. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443 [TBL] [Abstract][Full Text] [Related]
13. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]. Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497 [TBL] [Abstract][Full Text] [Related]
14. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study. Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980 [TBL] [Abstract][Full Text] [Related]
19. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068 [TBL] [Abstract][Full Text] [Related]
20. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels. Kuo PL; Lin CC; Lin YH; Guo HR J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]